The truth behind fetal tissue research


The abortion industry touts the amazing research done with the use of baby body parts, which is what they tell women when they consent to have an abortion – and donating the “fetal tissue” of their preborn baby post-abortion.

Putting aside the entire illegality and betrayal of having women sign intentionally deceptive consent forms that fail to say those baby body parts will be sold for profit, does fetal tissue research really add up to all it’s cracked up to be?

Looking through the massive report from the Select Panel on Infant Lives in the U.S. House of Representatives, who did a years worth of research and compiling evidence in the abortion industry’s fetal trafficking business, the answer would be no, fetal tissue research is all that the abortion industry claims it to be.

Below is from the Select Panel’s report:

Fetal tissue of aborted babies has not been and is not necessary for any kind of life-saving treatment for disease research. The abortion industry uses fruitless research to pressure women for their consent to hand over their aborted children for profit.

  • Early vaccine research did not depend on human fetal tissue
    • Vaccine research was begun by Edward Jenner in the late 1700s, more than 100 years before the first published use of human fetal tissue for biomedical research
    • While human fetal tissue cultures were used to first successfully create the polio virus in a laboratory and for basic research (which could have been accomplished using non-fetal or even non-human cells), the human fetal tissue did not result in a vaccine or a cure, nor has it ever been used to make the polio vaccine.
    • Fetal tissue and fetal cell lines were not used to develop the measles vaccine. It was instead created using cells from chicken eggs, human placentas, and adult kidneys.
    • The vaccine for mumps was not created using human fetal tissue. It was developed using cultures from monkey cells and chicken embryos.
    • While human fetal tissue has been used to produce a vaccine for Rubella, it was not used to develop the first vaccines, nor is it necessary for further research or production of rubella vaccines.
  • None of the nearly 75 vaccine formulations currently licensed in the United States is produced using freshly isolated human fetal tissue, according to data provided by the FDA (Exhibit 9.3 here). Some use cell lines created in the 1970s, but those vaccines don’t require new fetal tissue, and could be produced using non-fetal tissue.
  • Human fetal tissue is not required for research into human brain diseases such as Zika or Down syndrome. Tissue from other mammalian species can be used. For example, less than 1% of the more than 20,000 research articles on the development of neural tissue in the NIH database used human fetal tissue.
    • The major advances in our understanding of the Zika virus have not come from research involving human fetal tissue.
  • In the nearly 100 years that research using human fetal tissue has been unrestricted, not a single clinical treatment has been developed from human fetal tissue. In contrast, stem and progenitor cells from non-fetal tissues have rapidly yielded clinical treatments with proven benefits to patients. The select panel report includes specific data on how human fetal tissue has not been used or is not necessary for research or cures on a whole range of diseases, including Alzheimer’s, ALS, Diabetes, HIV/AIDS, preterm birth, spinal cord injury, and Zika.

All exhibits for this section can be found here: